NSE filing, NSE: EXIMROUTES. Summary written from the filing by ALFA Finder's alert engine.
Exim Routes Ltd: key numbers
- Share price
- ₹78.00
- Market cap
- ₹146.3 Cr
- Revenue (annual)
- ₹207.2 Cr
- Net profit (annual)
- ₹10.18 Cr
- P/E (TTM)
- 14.4×Sector 46.5×
- Promoter holding
- 52.83%
- FII holding
- 4.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Exim Routes Ltd
All →Exim Routes Other Announcement
Exim Routes Limited announced the shifting of its registered office within the same city of Gurugram. This change is intended to enhance operational and administrative efficiency.
Exim Routes Management Change
Exim Routes Limited has re-appointed Manish Goyal as Executive Director and Chairperson and appointed Shubham Ranjan Sinha as the company's Secretarial Auditor.
Exim Routes Other Announcement
Exim Routes Limited appointed M/s Subham Sinha & Associates as Secretarial Auditor for a five-year term, approved at the company's 7th Annual General Meeting.
Exim Routes Annual General Meeting
Exim Routes Limited held its 7th Annual General Meeting on September 30, 2026. The meeting covered the adoption of financial statements, director re-appointment, and ESOP disclosures.
Exim Routes Partnership
Exim Routes Limited signed an MoU with Al Shaheed Trading & Equipment Co. for strategic cooperation in sourcing and trading operations.
- From
- AL SHAHEED TRADING & EQUIPMENT CO.
- Execution
- 28th September 2026 to 31st March 2027
Exim Routes Annual General Meeting
Exim Routes Limited has issued the notice for its 7th Annual General Meeting scheduled for September 23, 2026. The meeting will address financial and secretarial business.
Other board meeting date announcements
All →Skybiotech Healthcare Board Meeting Date
Skybiotech Healthcare Ltd has scheduled a board meeting for November 10, 2026. The board will consider unaudited financial results for the quarter ended September 30, 2026.
Mathew Easow Research Securities Board Meeting Date
Mathew Easow Research Securities has scheduled a board meeting for November 13, 2026. The board will consider and approve unaudited financial results for the quarter ended September 30, 2026.
SSPN Finance Board Meeting Date
SSPN Finance Ltd's board will meet on November 14, 2026, to approve unaudited financial results for the half-year ended September 30, 2026.
BCL Enterprises Board Meeting Date
BCL Enterprises Ltd has scheduled a board meeting on November 12, 2026. The board will consider and approve unaudited financial results for the quarter and half-year ended September 30, 2026.
National Peroxide Board Meeting Date
National Peroxide Limited has scheduled a board meeting for November 11, 2026. The board will consider and approve unaudited financial results for the quarter and half-year ended September 30, 2026.
Marble City India Board Meeting Date
Marble City India will hold a board meeting on 14 November 2026 to consider unaudited standalone and consolidated half-year results for September 2026. The trading window stays closed from 1 October to 16 November 2026.